Bayesian Capital Management’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History
Bought
Maintained
Sold
Bayesian Capital Management's CVRS Position: Q4 2019 in Review
Bayesian Capital Management sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q4 2019, closing a stake of 81,500 shares — an estimated $349K sold.
Bayesian Capital Management first reported a position in CVRS in Q3 2019 and held it in 1 quarter. The position peaked at $349K in Q3 2019. 0 funds tracked by Wall St. Rank hold CVRS as of Q4 2019.
- Bayesian Capital Management reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q4 2019 after selling out during the quarter.
- Bayesian Capital Management sold 81,500 CORINDUS VASCULAR ROBOTICS, INC shares in Q4 2019, an estimated $349K.
- Bayesian Capital Management first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q3 2019 and held it in 1 quarter.
- Bayesian Capital Management's CORINDUS VASCULAR ROBOTICS, INC position peaked at $349K in Q3 2019.
- 0 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q4 2019.
Based on Bayesian Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.